These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6048488)

  • 1. Compounds acting on the central nervous system. VII. Studies in 1-pyridyl-4-substituted piperazines. A new class of anticonvulsants.
    Jain PC; Kapoor V; Anand N; Ahmad A; Patnaik GK
    J Med Chem; 1967 Sep; 10(5):812-8. PubMed ID: 6048488
    [No Abstract]   [Full Text] [Related]  

  • 2. Isoquinolines. 3. 3-Aminoisoquinoline derivatives with central nervous system depressant activity.
    Neumeyer JL; Weinhardt KK; Carrano RA; McCurdy DH
    J Med Chem; 1973 Jul; 16(7):808-13. PubMed ID: 4725927
    [No Abstract]   [Full Text] [Related]  

  • 3. Antidepressant and anticonvulsant activity of 1-(5-phenyl-4-oxazolin-2-yl)-4-substituted piperazines.
    Lee CM; Plotnikoff NP
    J Med Chem; 1976 May; 19(5):731-3. PubMed ID: 1271419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of trazodone.
    Silverstrini B; Lisciani R
    Curr Ther Res Clin Exp; 1973 Oct; 15(10):749-54. PubMed ID: 4201971
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis of N,N'-bis(3-substituted benzylideneaminopropyl)-piperazines and their anti-inflammatory, antiproteolytic, and anticonvulsant properties.
    Chaturvedi AK; Sastry BV; Chaudhari A; Parmar SS
    J Pharm Sci; 1976 Mar; 65(3):409-12. PubMed ID: 1263090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agents acting on the central nervous system. 14. 1-(p-Alkanoylphenoxy)-3-(N 4 -arylpiperazinyl)propan-2-ols. A new class of antidepressants.
    Rastogi SN; Anand N; Prasad CR
    J Med Chem; 1972 Mar; 15(3):286-91. PubMed ID: 5059212
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and properties of 4-substituted-1-piperazinyl-propyl derivatives of 1-phenyl-7-methylpyrimido-[4,5-d]pyrimidin-4-one.
    Malinka W; Zajac HE; Dereń A; Zawisza T; Wilimowski M; Kedzierska-Goździk L; Barczyńska J; Rutkowska M; Wojewódzki W; Szelag A
    Pol J Pharmacol Pharm; 1991; 43(5):369-79. PubMed ID: 1688093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Piperazine-derivatives. II. Effect of piperazine-derivatives].
    Lányi K; Erdélyi I; Institoris E; Tardos L; Szabó Z
    Arzneimittelforschung; 1968 Nov; 18(11):1431-5. PubMed ID: 5755908
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis and anticonvulsant activity of some piperazine derivatives.
    Marona H; Korona R; Szneler E
    Boll Chim Farm; 2004 Nov; 143(9):329-35. PubMed ID: 15881810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and anticonvulsant properties of new N-piperazinylalkyl imides of succinic acid.
    Obniska J; Kulig K; Zejc A
    Acta Pol Pharm; 1998; 55(3):223-31. PubMed ID: 9735703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological evaluation of delta2, 1,2,4-triazolin-5-one [1,3(4-m-chlorophenyl-1-piperazinyl)-propyl]-3,4-diethyl-hydrochloride (Etoperidone), a new potential antidepressant drug.
    Ramacci MT; Ghirardi O; Maccari F; Pacifici L; Sale P
    Arzneimittelforschung; 1979; 29(2):294-307. PubMed ID: 582144
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacological testing of a new anti-inflammatory agent: 1-(m-trifluoromethylphenyl)-N-nitroso anthranilic acid].
    Zoni G; Molinari ML; Banfi S
    Farmaco Sci; 1971 Jun; 26(6):525-46. PubMed ID: 5561809
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and pharmacological properties of N-aroyl-beta-(1-indanyl)-ethylamines.
    Misztal S; Bartyzel P; Chojnacka-Wójcik E; Tatarczyńska E; Sypniewska M
    Pol J Pharmacol Pharm; 1980; 32(4):577-85. PubMed ID: 7255273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological profile of a new psychotherapeutic agent: 4-p-fluorophenyl-5-N(N'-o-methoxyphenyl)piperazinoethyl-4-oxazolin-2-one (LR 511).
    Fregnan GB; Vidali M
    Pharmacology; 1977; 15(6):485-502. PubMed ID: 563604
    [No Abstract]   [Full Text] [Related]  

  • 15. New hybrid molecules with anticonvulsant and antinociceptive activity derived from 3-methyl- or 3,3-dimethyl-1-[1-oxo-1-(4-phenylpiperazin-1-yl)propan-2-yl]pyrrolidine-2,5-diones.
    Kamiński K; Zagaja M; Rapacz A; Łuszczki JJ; Andres-Mach M; Abram M; Obniska J
    Bioorg Med Chem; 2016 Feb; 24(4):606-18. PubMed ID: 26746343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel 4-substituted 2-piperazinylquinazolines as potent anticonvulsive and antihypoxic agents.
    Hori M; Iemura R; Hara H; Ozaki A; Sukamoto T; Ohtaka H
    Chem Pharm Bull (Tokyo); 1990 May; 38(5):1286-91. PubMed ID: 2393953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug research on norbornan derivatives. 2].
    Krieger H
    Arzneimittelforschung; 1968 Mar; 18(3):324-30. PubMed ID: 4387156
    [No Abstract]   [Full Text] [Related]  

  • 18. Some new piperazino derivatives as antiparkinson and anticonvulsant agents.
    Agarwal JC; Nath C; Sharma M; Gupta GP; Bhargava KP; Shanker K
    Arch Pharm (Weinheim); 1983 Aug; 316(8):690-4. PubMed ID: 6625875
    [No Abstract]   [Full Text] [Related]  

  • 19. Preliminary evaluation of anticonvulsant activity and neurotoxicity of some 1,4-substituted piperazine derivatives.
    Marona H; Gunia A; Słoczyńska K; Rapacz A; Filipek B; Cegła M; Opoka W
    Acta Pol Pharm; 2009; 66(5):571-8. PubMed ID: 19894654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drugs acting on the central nervous system].
    Recenti Prog Med; 1982 Oct; 73(4):462-478. PubMed ID: 6130574
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.